. Author manuscript; available in PMC: 2019 Nov 1.

Published in final edited form as: Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S3–S7. doi: 10.1053/j.ajkd.2018.06.021

Table 1:

Select Healthy People 2020 Indicators of CKD Care, by Race/Ethnicity

	Black/African American		White		HP 2020 Target
	2006	2015^*	2006	2015^*
% of persons with diagnosed DM who obtain an annual urinary albumin measurement	29.5%	46.0%	31.4	47.5%^***	37%
% of persons with DM and CKD who receive medical evaluation with measurement of Scr, urinary albumin, HbA1c, lipids, and eye exam	18.8%	27.6%	21.4%	30.2%	25.3%
% of persons with DM and CKD who receive recommended medical treatment with ACEi or ARBs	66.7%	72.3%	62.2%	70.2%	76.3%
% CKD patients receiving care from a nephrologist at least 12 mo before RRT start	23.2%	32%	27.9%	37%	30.4%
Rate of new cases of ESKD per million population	1114	895	294	312.1	352
% patients receiving a kidney transplant within 3 y of ESKD	9.1%	7%^**	21%	16.2^**	20.1
No. of deaths per 1,000 patient-years for persons on dialysis	170.9	135.8	258.1	207.4	187.4

Unless otherwise indicated

^**

2012

^***

2014

DM – diabetes mellitus; ESKD – end-stage kidney disease; angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II receptor blocker (ARB); Scr, serum creatinine; HbA_1c, hemoglobin A_1c. HP 2020, Healthy People 2020; RRT, renatl replacement therap

Source: USRDS 2017 Annual Data Report¹³